Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Advanced HR-positive and HER2-negative Breast Cancer; CDK4/6 Inhibitor Treatment Failed × dalpiciclib × 1 year × Clear all

Sponsor

Conditions

Breast Neoplasms 8 HR+/HER2- Advanced Breast Cancer 1 HR Positive HER2 Negative Advanced Breast Cancer 1 HER2-positive Breast Cancer 1 Advanced Breast Cancer 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡